CRYO-CELL INTERNATIONAL, INC. Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested, Number of Shares
CRYO-CELL INTERNATIONAL, INC. (CCEL) reported Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested, Number of Shares of 85.73 thousand shares for the 6-month period ending 2026-05-31, per its 10-Q filed 2026-07-15.
Financial Statements › Notes › Compensation Related Costs › Share-Based Payment Arrangement, Disclosure
us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedNumberOfShares · last filed 2026-07-15
- CRYO-CELL INTERNATIONAL, INC. share-based compensation arrangement by share-based payment award, options, vested, number of shares for the quarter ending 2026-05-31 was 2.65K shares, a 68.70% decline year-over-year.
- CRYO-CELL INTERNATIONAL, INC. share-based compensation arrangement by share-based payment award, options, vested, number of shares for the quarter ending 2026-02-28 was 83.08K shares, a 17.43% decline year-over-year.
- CRYO-CELL INTERNATIONAL, INC. share-based compensation arrangement by share-based payment award, options, vested, number of shares for the quarter ending 2025-11-30 was 3.99K shares, a 8.37% decline year-over-year.
- CRYO-CELL INTERNATIONAL, INC. share-based compensation arrangement by share-based payment award, options, vested, number of shares for the quarter ending 2025-08-31 was 4.35K shares, a 0.00% change year-over-year.
- CRYO-CELL INTERNATIONAL, INC. share-based compensation arrangement by share-based payment award, options, vested, number of shares for fiscal 2025 was 117.41K shares, a 22.52% increase from fiscal 2024.
- CRYO-CELL INTERNATIONAL, INC. share-based compensation arrangement by share-based payment award, options, vested, number of shares for fiscal 2024 was 95.83K shares, a 8.64% decline from fiscal 2023.
- CRYO-CELL INTERNATIONAL, INC. share-based compensation arrangement by share-based payment award, options, vested, number of shares for fiscal 2023 was 104.89K shares, a 356.41% increase from fiscal 2022.
- CRYO-CELL INTERNATIONAL, INC. share-based compensation arrangement by share-based payment award, options, vested, number of shares for fiscal 2022 was 22.98K shares, a 65.31% decline from fiscal 2021.
| Period end | Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested, Number of Shares 3 month | Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested, Number of Shares 6 month | Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested, Number of Shares 9 month | Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested, Number of Shares 12 month |
|---|---|---|---|---|
| 2026-05-31 | 2.65K shares derived: 10-Q 6 month − 10-Q 3 month · filed 2026-07-15 | 85.73K shares 10-Q · filed 2026-07-15 | 89.71K shares derived: sum of 3 quarters · filed 2026-07-15 | 94.06K shares derived: sum of 4 quarters · filed 2026-07-15 |
| 2026-02-28 | 83.08K shares 10-Q · filed 2026-04-14 | 87.06K shares derived: sum of 2 quarters · filed 2026-04-14 | 91.41K shares derived: sum of 3 quarters · filed 2026-04-14 | 99.88K shares derived: sum of 4 quarters · filed 2026-04-14 |
| 2025-11-30 | 3.99K shares derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-27 | 8.34K shares derived: sum of 2 quarters · filed 2026-02-27 | 16.80K shares derived: sum of 3 quarters · filed 2026-02-27 | 117.41K shares 10-K · filed 2026-02-27 |
| 2025-08-31 | 4.35K shares derived: 10-Q 9 month − 10-Q 6 month · filed 2025-10-15 | 12.82K shares derived: sum of 2 quarters · filed 2025-10-15 | 113.43K shares 10-Q · filed 2025-10-15 | 117.78K shares derived: sum of 4 quarters · filed 2025-10-15 |
| 2025-05-31 | 8.47K shares derived: 10-Q 6 month − 10-Q 3 month · filed 2025-07-15 | 109.08K shares 10-Q · filed 2025-07-15 | 113.43K shares derived: sum of 3 quarters · filed 2025-07-15 | 117.78K shares derived: sum of 4 quarters · filed 2025-07-15 |
| 2025-02-28 | 100.61K shares 10-Q · filed 2025-04-14 | 104.96K shares derived: sum of 2 quarters · filed 2025-04-14 | 109.31K shares derived: sum of 3 quarters · filed 2025-04-14 | 118.66K shares derived: sum of 4 quarters · filed 2025-04-14 |
| 2024-11-30 | 4.35K shares derived: 10-K 12 month − 10-Q 9 month · filed 2025-02-28 | 8.70K shares derived: sum of 2 quarters · filed 2025-02-28 | 18.05K shares derived: sum of 3 quarters · filed 2025-02-28 | 95.83K shares 10-K · filed 2025-02-28 |
| 2024-08-31 | 4.35K shares derived: 10-Q 9 month − 10-Q 6 month · filed 2024-10-15 | 13.70K shares derived: sum of 2 quarters · filed 2024-10-15 | 91.48K shares 10-Q · filed 2024-10-15 | 95.83K shares derived: sum of 4 quarters · filed 2024-10-15 |
| 2024-05-31 | 9.35K shares derived: 10-Q 6 month − 10-Q 3 month · filed 2024-07-15 | 87.13K shares 10-Q · filed 2024-07-15 | 91.48K shares derived: sum of 3 quarters · filed 2024-07-15 | 95.83K shares derived: sum of 4 quarters · filed 2024-07-15 |
| 2024-02-29 | 77.78K shares 10-Q · filed 2024-04-15 | 82.13K shares derived: sum of 2 quarters · filed 2024-04-15 | 86.48K shares derived: sum of 3 quarters · filed 2024-04-15 | 95.83K shares derived: sum of 4 quarters · filed 2024-04-15 |
| 2023-11-30 | 4.35K shares derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-28 | 8.70K shares derived: sum of 2 quarters · filed 2024-02-28 | 18.05K shares derived: sum of 3 quarters · filed 2024-02-28 | 104.89K shares 10-K · filed 2024-02-28 |
| 2023-08-31 | 4.35K shares derived: 10-Q 9 month − 10-Q 6 month · filed 2023-10-12 | 13.70K shares derived: sum of 2 quarters · filed 2023-10-12 | 100.54K shares 10-Q · filed 2023-10-12 | 104.89K shares derived: sum of 4 quarters · filed 2023-10-12 |
| 2023-05-31 | 9.35K shares derived: 10-Q 6 month − 10-Q 3 month · filed 2023-07-14 | 96.19K shares 10-Q · filed 2023-07-14 | 100.54K shares derived: sum of 3 quarters · filed 2023-07-14 | 104.97K shares derived: sum of 4 quarters · filed 2023-07-14 |
| 2023-02-28 | 86.84K shares 10-Q · filed 2023-04-21 | 91.19K shares derived: sum of 2 quarters · filed 2023-04-21 | 95.62K shares derived: sum of 3 quarters · filed 2023-04-21 | 105.22K shares derived: sum of 4 quarters · filed 2023-04-21 |
| 2022-11-30 | 4.35K shares derived: 10-K 12 month − 10-Q 9 month · filed 2023-02-28 | 8.78K shares derived: sum of 2 quarters · filed 2023-02-28 | 18.38K shares derived: sum of 3 quarters · filed 2023-02-28 | 22.98K shares 10-K · filed 2023-02-28 |
| 2022-08-31 | 4.43K shares derived: 10-Q 9 month − 10-Q 6 month · filed 2022-10-18 | 14.03K shares derived: sum of 2 quarters · filed 2022-10-18 | 18.63K shares 10-Q · filed 2022-10-18 | 39.99K shares derived: sum of 4 quarters · filed 2022-10-18 |
| 2022-05-31 | 9.60K shares derived: 10-Q 6 month − 10-Q 3 month · filed 2022-07-11 | 14.20K shares 10-Q · filed 2022-07-11 | 35.56K shares derived: sum of 3 quarters · filed 2022-07-11 | 49.48K shares derived: sum of 4 quarters · filed 2022-07-11 |
| 2022-02-28 | 4.60K shares 10-Q · filed 2022-04-13 | 25.96K shares derived: sum of 2 quarters · filed 2022-04-13 | 39.88K shares derived: sum of 3 quarters · filed 2022-04-13 | 47.13K shares derived: sum of 4 quarters · filed 2022-04-13 |
| 2021-11-30 | 21.36K shares derived: 10-K 12 month − 10-Q 9 month · filed 2022-02-22 | 35.28K shares derived: sum of 2 quarters · filed 2022-02-22 | 42.53K shares derived: sum of 3 quarters · filed 2022-02-22 | 66.25K shares 10-K · filed 2022-02-22 |
| 2021-08-31 | 13.92K shares derived: 10-Q 9 month − 10-Q 6 month · filed 2021-10-15 | 21.17K shares derived: sum of 2 quarters · filed 2021-10-15 | 44.89K shares 10-Q · filed 2021-10-15 | 79.28K shares derived: sum of 4 quarters · filed 2021-10-15 |
| 2021-05-31 | 7.25K shares derived: 10-Q 6 month − 10-Q 3 month · filed 2021-07-15 | 30.97K shares 10-Q · filed 2021-07-15 | 65.37K shares derived: sum of 3 quarters · filed 2021-07-15 | 93.66K shares derived: sum of 4 quarters · filed 2021-07-15 |
| 2021-02-28 | 23.72K shares 10-Q · filed 2021-04-14 | 58.12K shares derived: sum of 2 quarters · filed 2021-04-14 | 86.41K shares derived: sum of 3 quarters · filed 2021-04-14 | 98.66K shares derived: sum of 4 quarters · filed 2021-04-14 |
| 2020-11-30 | 34.40K shares derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-01 | 62.69K shares derived: sum of 2 quarters · filed 2021-03-01 | 74.94K shares derived: sum of 3 quarters · filed 2021-03-01 | 137.02K shares 10-K · filed 2021-03-01 |
| 2020-08-31 | 28.29K shares derived: 10-Q 9 month − 10-Q 6 month · filed 2020-10-15 | 40.54K shares derived: sum of 2 quarters · filed 2020-10-15 | 102.63K shares 10-Q · filed 2020-10-15 | 107.85K shares derived: sum of 4 quarters · filed 2020-10-15 |
| 2020-05-31 | 12.25K shares derived: 10-Q 6 month − 10-Q 3 month · filed 2020-07-10 | 74.33K shares 10-Q · filed 2020-07-10 | 79.56K shares derived: sum of 3 quarters · filed 2020-07-10 | 114.05K shares derived: sum of 4 quarters · filed 2020-07-10 |
| 2020-02-29 | 62.08K shares 10-Q · filed 2020-04-14 | 67.31K shares derived: sum of 2 quarters · filed 2020-04-14 | 101.80K shares derived: sum of 3 quarters · filed 2020-04-14 | 103.30K shares derived: sum of 4 quarters · filed 2020-04-14 |
| 2019-11-30 | 5.23K shares derived: 10-K 12 month − 10-Q 9 month · filed 2020-02-28 | 39.72K shares derived: sum of 2 quarters · filed 2020-02-28 | 41.22K shares derived: sum of 3 quarters · filed 2020-02-28 | 58.43K shares 10-K · filed 2020-02-28 |
| 2019-08-31 | 34.49K shares derived: 10-Q 9 month − 10-Q 6 month · filed 2019-10-15 | 35.99K shares derived: sum of 2 quarters · filed 2019-10-15 | 53.20K shares 10-Q · filed 2019-10-15 | |
| 2019-05-31 | 1.50K shares derived: 10-Q 6 month − 10-Q 3 month · filed 2019-07-15 | 18.71K shares 10-Q · filed 2019-07-15 | ||
| 2019-02-28 | 17.21K shares 10-Q · filed 2019-04-15 | |||
| 2018-11-30 | 50.55K shares 10-K · filed 2019-02-28 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| MANGOCEUTICALS, INC. (MGRX) | United States | $0.010B | -0.43 |
| BioRestorative Therapies, Inc. (BRTX) | United States | $0.064B | |
| Park Dental Partners, Inc. (PARK) | United States | $0.094B | |
| VIEMED HEALTHCARE, INC. (VMD) | United States | $0.336B | 29.92 |
| agilon health, inc. (AGL) | United States | $1.272B | -7.76 |
| Progyny, Inc. (PGNY) | United States | $1.994B | 28.37 |
| Sotera Health Co (SHC) | United States | $5.271B | 30.96 |
| DAVITA INC. (DVA) | United States | $11.147B | 16.80 |